Women's Health August 21, 2026 0 Comments

This Revolutionary Pill Promises to Replace Hours at the Gym—But Can It Really Deliver?

Imagine if you could skip the treadmill, dodge the dumbbells, and still reap the perks of a good sweat session—would you take it? Well, hold onto your shaker bottle, because science is edging closer to making that a reality. A groundbreaking pill named ENV-308 just cleared its first hurdle in human trials, mimicking the hormone your body pumps out during intense exercise. Now, before you start dreaming of a lazy Sunday with zero guilt, let’s pump the brakes. This isn’t a gym membership substitute just yet, but the buzz around this little capsule is definitely worth a second look. Wondering how it stacks against the reigning champs—GLP-1 meds? Or who stands to benefit from this futuristic fitness shortcut? Grab a seat; this ride’s just warming up. LEARN MORE

4 min read

A pill designed to mimic the effects of exercise just passed its first human clinical trial.
ENV-308 appears to be safe in humans, according to the findings.
But doctors say we’re a long way off from taking a pill to get the perks of exercise—here’s why.

While you may know deep in your heart and soul that exercise is an important part of overall health, some people just have more time, interest, and ability to work out than others. If your relationship with going hard at the gym is more hate than love, there may be some good news on the horizon for you: Scientists have created a pill that mimics some of the effects of exercise—and it just passed its first trial in humans.

The pill is called ENV-308, and it’s designed to mimic a hormone that’s produced when you work out. We’re a long way from saying you should pop a pill instead of hitting the gym, but the information we have so far for this medication is definitely intriguing. Naturally, ENV-308 raises comparisons to GLP-1s. If the pill continues to pass other needed trials, could ENV-308 replace GLP-1s as the “it” medication for losing weight? Here’s what doctors have to say about it.

Meet the experts: Christine Bonarrigo, PharmD, weight management clinical pharmacist at Tufts Medical Center; Paul Sack, MD, an endocrinologist at MedStar Health; Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California

What has the company reported so far?

The news is based on Phase 1 clinical trial results that looked at the safety and tolerability of ENV-308 on 88 healthy adults. Keep in mind, this trial wasn’t designed to see how effective the drug is, but rather because researchers just wanted to make sure there were no horrible side effects or issues.

They discovered that the participants tolerated the medication “well” and, notably, that there was an “exceptional” gastrointestinal safety profile. Because nausea, vomiting, and other GI issues are common with GLP-1s, researchers were especially interested in gauging these potential issues with ENV-308. None of the participants had serious side effects or stopped the medication during the trial.

The study also looked at the impact of ENV-308 on leptin, a hormone that’s released by fat cells to control appetite. People who are obese typically have leptin levels that are chronically elevated. The Phase 1 trial found that the pill reduced circulating leptin, but the findings don’t show that the drug causes weight loss or improves leptin sensitivity.

The company also said in a press release that it hopes this medication can both help people maintain their weight loss and hold onto their muscle mass after a weight-loss journey.

How does ENV-308 work?

ENV-308 mimics a molecule called Lac-Phe, which is a hormone the body releases during intense exercise and after meals. Lac-Phe helps to suppress your appetite, but it’s cleared too quickly by the body on its own to help with weight loss or weight maintenance. ENV-308 aims to capture the effects of Lac-Phe in a daily oral pill.

What’s the difference between ENV-308 and GLP-1 medications?

These medications work in two very different ways. “GLP-1 medications such as semaglutide and tirzepatide act on incretin pathways that regulate appetite, blood sugar, and digestion,” explains Christine Bonarrigo, PharmD, weight management clinical pharmacist at Tufts Medical Center. “ENV-308 is an investigational oral drug designed to mimic Lac-Phe, a signaling molecule produced by the body after intense exercise.”

The hormonal pathway stimulated by ENV-308 is “very different” from that stimulated by GLP-1s, says Paul Sack, MD, an endocrinologist at MedStar Health. There’s also a lot more to explore here. “It has only been shown to cause weight loss without losing muscle mass in animal studies,” he says. Beyond that, we still don’t know much.

“The recent Phase 1 results provide encouraging preliminary safety and tolerability data, but we don’t yet have human data showing how much weight ENV-308 can help people lose,” Bonarrigo says.

Who would this benefit?

While ENV-308 is designed to help people with obesity, beyond that, there’s still a lot up in the air. It’s possible that this could be a good treatment for people who want to lose a significant amount of weight but are concerned about muscle loss or GI side effects, says Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California.

But it may also be something that people use alongside a GLP-1. “It seems that it’s more designed to complement GLP-1s or maybe for maintenance after weight loss,” Dr. Ali says.

When will this be available?

While the idea of “exercising” through a pill is appealing, we’re a long way off from that becoming the new reality.

There are a lot more questions than answers with ENV-308 right now. “We don’t even know what the weight loss effects or changes in muscle mass will be in obese individuals,” Dr. Sack says. Even if everything goes well in clinical trials, Dr. Ali says that it will likely be “years” before this medication is available to the general public.

Until then, hitting the gym is still the best way to get exercise-like results for both your body and mind.

Carina Hsieh, MPH, is the deputy features editor of Women’s Health. She has more than a decade’s worth of experience working in media and has covered everything from beauty, fashion, travel, lifestyle, pets, to health.

She began her career as an intern in the fashion closet at Cosmopolitan where she worked her way up to Senior Sex & Relationships Editor. While covering women’s health there, she discovered her passion for health service journalism and took a break to get her Masters in Public Health. Post-grad school, she worked as a freelance writer and as The Daily Beast’s first Beauty, Health, and Wellness Reporter.

Carina is an alum of the Fashion Institute of Technology and the Yale School of Public Health. She and her French Bulldog, Bao Bao, split their time between Brooklyn and Connecticut. She enjoys reformer Pilates, (slow) running, and smelling the fancy toiletries in boutique fitness class locker rooms.